At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Journey II Bi-Cruciate Stabilized TKA +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-center In Vivo Kinematics for Subjects Implanted With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA
In Brief
An observational study evaluating Journey II Bi-Cruciate Stabilized TKA, Journey II Cruciate Retaining TKA, and 1 other intervention for Knee Osteoarthritis and 2 related conditions. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis, Total Knee Arthroplasty, Knee
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartOct 2020
First PostedNov 2020
Primary CompletionMay 2022
TodayJul 2026
First PostedNov 2, 2020
Enrollment StartOct 22, 2020
Primary CompletionMay 16, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.7 years ago
Interventions
Journey II Bi-Cruciate Stabilized TKAdevice
Total Knee Arthroplasty System
Journey II Cruciate Retaining TKAdevice
Total Knee Arthroplasty System
Journey II Bi-Cruciate Retaining TKAdevice
Total Knee Arthroplasty System